Edwards Change To Inventory vs End Period Cash Flow Analysis

EW Stock  USD 73.32  0.65  0.88%   
Edwards Lifesciences financial indicator trend analysis is much more than just examining Edwards Lifesciences Corp latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Edwards Lifesciences Corp is a good investment. Please check the relationship between Edwards Lifesciences Change To Inventory and its End Period Cash Flow accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.

Change To Inventory vs End Period Cash Flow

Change To Inventory vs End Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Edwards Lifesciences Corp Change To Inventory account and End Period Cash Flow. At this time, the significance of the direction appears to have strong contrarian relationship.
The correlation between Edwards Lifesciences' Change To Inventory and End Period Cash Flow is -0.61. Overlapping area represents the amount of variation of Change To Inventory that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Edwards Lifesciences Corp, assuming nothing else is changed. The correlation between historical values of Edwards Lifesciences' Change To Inventory and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Change To Inventory of Edwards Lifesciences Corp are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Change To Inventory i.e., Edwards Lifesciences' Change To Inventory and End Period Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.61
Relationship DirectionNegative 
Relationship StrengthWeak

Change To Inventory

The increase or decrease in the amount of inventory a company has over a certain period.

End Period Cash Flow

Most indicators from Edwards Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
At this time, Edwards Lifesciences' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.36 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 169.1 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit4.0B4.3B4.6B4.9B
Total Revenue5.2B5.4B6.0B6.3B

Edwards Lifesciences fundamental ratios Correlations

0.680.880.990.970.920.990.80.810.970.7-0.910.720.960.96-0.630.760.940.960.480.93-0.680.730.850.810.4
0.680.430.720.720.780.680.660.450.710.29-0.670.390.720.77-0.750.350.740.650.050.54-0.480.40.450.650.31
0.880.430.820.80.690.870.650.740.850.74-0.80.680.850.77-0.340.810.770.850.610.91-0.470.610.770.640.25
0.990.720.820.990.950.980.840.750.970.66-0.90.630.970.98-0.690.670.970.940.370.87-0.680.750.790.810.34
0.970.720.80.990.930.980.80.710.970.67-0.860.640.960.98-0.660.670.960.910.320.87-0.70.780.770.840.31
0.920.780.690.950.930.890.930.730.930.45-0.870.520.930.96-0.870.530.960.910.270.73-0.660.580.730.790.35
0.990.680.870.980.980.890.770.720.950.76-0.870.70.940.95-0.580.750.920.90.460.92-0.610.80.790.790.36
0.80.660.650.840.80.930.770.610.830.33-0.80.290.880.84-0.860.350.910.810.190.58-0.540.440.620.740.16
0.810.450.740.750.710.730.720.610.760.42-0.830.780.720.74-0.550.750.680.920.630.8-0.690.320.930.630.61
0.970.710.850.970.970.930.950.830.760.61-0.880.630.980.95-0.670.680.960.950.320.87-0.750.670.820.790.28
0.70.290.740.660.670.450.760.330.420.61-0.520.720.630.57-0.040.810.550.560.60.79-0.350.880.590.530.37
-0.91-0.67-0.8-0.9-0.86-0.87-0.87-0.8-0.83-0.88-0.52-0.59-0.9-0.880.62-0.59-0.88-0.93-0.48-0.830.62-0.52-0.85-0.75-0.46
0.720.390.680.630.640.520.70.290.780.630.72-0.590.570.59-0.270.960.480.720.760.85-0.560.540.820.590.74
0.960.720.850.970.960.930.940.880.720.980.63-0.90.570.96-0.680.630.980.930.330.85-0.690.690.790.840.26
0.960.770.770.980.980.960.950.840.740.950.57-0.880.590.96-0.740.620.970.930.30.83-0.690.70.760.850.3
-0.63-0.75-0.34-0.69-0.66-0.87-0.58-0.86-0.55-0.67-0.040.62-0.27-0.68-0.74-0.22-0.74-0.67-0.05-0.370.51-0.23-0.48-0.64-0.3
0.760.350.810.670.670.530.750.350.750.680.81-0.590.960.630.62-0.220.530.740.780.88-0.50.610.790.580.6
0.940.740.770.970.960.960.920.910.680.960.55-0.880.480.980.97-0.740.530.910.230.78-0.690.680.740.820.22
0.960.650.850.940.910.910.90.810.920.950.56-0.930.720.930.93-0.670.740.910.480.89-0.760.550.920.790.44
0.480.050.610.370.320.270.460.190.630.320.6-0.480.760.330.3-0.050.780.230.480.61-0.060.310.610.320.74
0.930.540.910.870.870.730.920.580.80.870.79-0.830.850.850.83-0.370.880.780.890.61-0.670.710.890.80.44
-0.68-0.48-0.47-0.68-0.7-0.66-0.61-0.54-0.69-0.75-0.350.62-0.56-0.69-0.690.51-0.5-0.69-0.76-0.06-0.67-0.44-0.8-0.68-0.26
0.730.40.610.750.780.580.80.440.320.670.88-0.520.540.690.7-0.230.610.680.550.310.71-0.440.510.620.21
0.850.450.770.790.770.730.790.620.930.820.59-0.850.820.790.76-0.480.790.740.920.610.89-0.80.510.750.6
0.810.650.640.810.840.790.790.740.630.790.53-0.750.590.840.85-0.640.580.820.790.320.8-0.680.620.750.31
0.40.310.250.340.310.350.360.160.610.280.37-0.460.740.260.3-0.30.60.220.440.740.44-0.260.210.60.31
Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.5B7.2B8.5B8.3B9.4B9.8B
Other Current Liab6.4M574.7M677.3M673.3M821.9M863.0M
Total Current Liabilities902.4M893.9M1.0B1.0B1.2B1.3B
Total Stockholder Equity4.1B4.6B5.8B5.8B6.7B7.0B
Property Plant And Equipment Net1.1B1.5B1.6B1.7B1.8B1.9B
Retained Earnings3.7B4.6B6.1B7.6B9.0B9.4B
Non Current Assets Total3.5B4.1B5.3B5.2B5.3B5.6B
Non Currrent Assets Other101.8M119.6M110.8M299.1M463.7M486.9M
Cash And Short Term Investments1.5B1.4B1.5B1.2B1.6B1.7B
Net Receivables599.1M602.8M664.9M699.1M836.9M878.7M
Good Will1.2B1.2B1.2B1.2B1.3B688.6M
Common Stock Shares Outstanding636.6M631.9M631.2M624.2M609.4M550.8M
Liabilities And Stockholders Equity6.5B7.2B8.5B8.3B9.4B9.8B
Non Current Liabilities Total1.4B1.8B1.6B1.5B1.4B800.7M
Inventory640.9M802.3M726.7M875.5M1.2B1.2B
Other Current Assets168M283.3M322.3M305.9M386.1M405.4M
Other Stockholder Equity344.6M(466M)(716.5M)(2.2B)(2.8B)(2.6B)
Total Liab2.3B2.7B2.7B2.5B2.6B1.4B
Property Plant And Equipment Gross1.1B1.5B1.6B1.7B2.7B2.8B
Total Current Assets3.0B3.1B3.2B3.1B4.0B4.2B
Accumulated Other Comprehensive Income(156M)(161.1M)(157.7M)(254.9M)(242.8M)(230.7M)
Short Long Term Debt Total593.8M678.8M694.9M690.3M691.3M486.4M
Other Liab784.1M1.1B969.6M797.6M917.2M963.1M
Net Debt(500.3M)(488.3M)(172.5M)(77.7M)(449.1M)(426.6M)
Accounts Payable180.4M196.5M204.5M201.9M201.4M139.5M
Cash1.2B1.2B862.8M769M1.1B1.2B
Other Assets274M1.2B357.5M783.1M900.6M945.6M
Long Term Debt594.4M595M595.7M596.3M597M425.6M
Common Stock Total Equity218.1M636.4M642M646.3M743.2M780.4M
Short Term Debt0.025.5M54.4M51M49.8M47.3M
Intangible Assets336.5M331.4M323.6M285.2M428.4M449.8M
Common Stock218.1M636.4M642M646.3M650.5M683.0M
Property Plant Equipment1.1B1.4B1.6B1.7B2.0B2.1B
Treasury Stock(1.0B)(1.3B)(1.9B)(2.4B)(2.2B)(2.1B)
Short Term Investments337.8M219.4M604M446.3M500.5M382.6M
Net Tangible Assets2.9B3.4B4.3B4.4B5.0B5.3B
Retained Earnings Total Equity3.7B4.6B6.1B7.6B8.7B9.2B
Capital Surpluse1.6B1.4B1.7B2.0B2.3B1.2B
Long Term Investments585.5M801.6M1.8B1.2B583.9M582.2M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Edwards Stock Analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.